Header Logo

Ryan Nipp

Concepts (381)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms
70
2025
808
15.820
Why?
Palliative Care
26
2024
82
6.300
Why?
Pancreatic Neoplasms
19
2025
540
5.390
Why?
Gastrointestinal Neoplasms
15
2025
40
5.370
Why?
Quality of Life
35
2025
487
5.070
Why?
Patient Reported Outcome Measures
15
2025
64
4.650
Why?
Medical Oncology
9
2025
94
4.420
Why?
Hospitalization
18
2023
198
4.200
Why?
Aged
89
2025
5400
3.710
Why?
Lung Neoplasms
13
2022
356
3.410
Why?
Humans
150
2025
28094
3.190
Why?
Cost of Illness
12
2025
54
3.060
Why?
Adenocarcinoma
9
2025
298
3.030
Why?
Terminal Care
9
2022
43
2.600
Why?
Male
86
2025
13489
2.320
Why?
Clinical Trials as Topic
6
2023
214
2.310
Why?
Middle Aged
65
2025
7137
2.290
Why?
Aged, 80 and over
38
2025
2021
2.150
Why?
Female
89
2025
15153
2.120
Why?
Depression
13
2021
216
2.100
Why?
Carcinoma, Non-Small-Cell Lung
6
2022
105
2.040
Why?
Patient Acceptance of Health Care
6
2025
97
1.890
Why?
Patient Participation
7
2021
56
1.840
Why?
Caregivers
10
2025
118
1.790
Why?
Antineoplastic Agents
9
2024
679
1.710
Why?
Adaptation, Psychological
8
2025
122
1.590
Why?
Health Care Costs
5
2020
50
1.490
Why?
Carcinoma, Pancreatic Ductal
6
2021
138
1.470
Why?
Antineoplastic Combined Chemotherapy Protocols
9
2023
409
1.450
Why?
Geriatric Assessment
6
2025
89
1.420
Why?
Surveys and Questionnaires
20
2025
971
1.420
Why?
Sarcopenia
3
2021
42
1.420
Why?
Adult
40
2025
7739
1.350
Why?
Patient Readmission
3
2022
103
1.330
Why?
Health Services Accessibility
5
2021
100
1.300
Why?
Prognosis
21
2025
802
1.300
Why?
Patient Selection
4
2021
148
1.250
Why?
Neoadjuvant Therapy
6
2024
73
1.220
Why?
Geriatrics
2
2021
47
1.190
Why?
Symptom Assessment
4
2022
15
1.130
Why?
Colorectal Neoplasms
6
2021
138
1.090
Why?
Cancer Survivors
4
2021
43
1.050
Why?
Carcinoma, Squamous Cell
3
2024
163
1.040
Why?
Esophageal Neoplasms
2
2024
32
1.000
Why?
Physician-Patient Relations
4
2020
115
0.990
Why?
Camptothecin
2
2015
16
0.960
Why?
Cross-Sectional Studies
17
2025
961
0.940
Why?
Artificial Intelligence
1
2025
53
0.930
Why?
Medicare Part D
1
2024
5
0.910
Why?
Survivors
5
2021
40
0.910
Why?
Prescription Drugs
1
2024
15
0.900
Why?
Lobbying
1
2024
9
0.890
Why?
Germ-Line Mutation
1
2024
30
0.890
Why?
Telemedicine
4
2025
174
0.880
Why?
Informed Consent
2
2021
25
0.870
Why?
Genetic Testing
1
2024
68
0.860
Why?
United States
15
2025
2146
0.830
Why?
Medicare
5
2020
124
0.830
Why?
Affect
4
2020
85
0.820
Why?
Inpatients
2
2022
56
0.810
Why?
SEER Program
7
2023
47
0.810
Why?
Body Composition
3
2021
265
0.760
Why?
Length of Stay
6
2023
229
0.760
Why?
Treatment Outcome
7
2021
2377
0.760
Why?
Personal Satisfaction
1
2022
31
0.750
Why?
Healthcare Disparities
3
2021
90
0.740
Why?
Insurance Coverage
5
2021
31
0.740
Why?
Severity of Illness Index
3
2019
452
0.740
Why?
Anxiety
9
2022
149
0.730
Why?
Activities of Daily Living
3
2025
106
0.720
Why?
Hematology
1
2021
25
0.710
Why?
Head and Neck Neoplasms
1
2022
87
0.700
Why?
Health Expenditures
7
2025
30
0.700
Why?
Muscle, Skeletal
4
2021
634
0.690
Why?
Analgesics, Opioid
1
2022
113
0.690
Why?
Registries
3
2021
387
0.690
Why?
Hospice Care
5
2021
15
0.680
Why?
Electronics
1
2020
4
0.670
Why?
Monitoring, Physiologic
1
2020
57
0.650
Why?
Randomized Controlled Trials as Topic
6
2025
385
0.640
Why?
Income
2
2019
38
0.640
Why?
Financial Statements
1
2019
2
0.630
Why?
Financing, Personal
1
2019
4
0.630
Why?
Travel
1
2019
12
0.630
Why?
Monitoring, Ambulatory
1
2019
26
0.620
Why?
Early Detection of Cancer
1
2020
126
0.610
Why?
Pain Management
2
2025
58
0.610
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2023
44
0.610
Why?
Self Report
4
2022
120
0.610
Why?
Emergency Service, Hospital
1
2020
120
0.600
Why?
Antidepressive Agents
1
2018
29
0.590
Why?
Patient Protection and Affordable Care Act
1
2018
10
0.590
Why?
Leukemia, Myeloid, Acute
2
2022
37
0.590
Why?
Age Factors
7
2021
734
0.590
Why?
Breast Neoplasms
6
2020
459
0.580
Why?
Decision Making
6
2025
175
0.570
Why?
Stress Disorders, Post-Traumatic
1
2018
69
0.550
Why?
Multimorbidity
1
2017
3
0.550
Why?
Communication
2
2019
178
0.550
Why?
Drug Industry
1
2016
14
0.530
Why?
Conflict of Interest
1
2016
16
0.530
Why?
Delivery of Health Care
4
2024
118
0.530
Why?
Pragmatic Clinical Trials as Topic
1
2016
5
0.520
Why?
Pancreatectomy
1
2017
58
0.520
Why?
Prospective Studies
11
2023
1248
0.510
Why?
Young Adult
10
2023
2732
0.500
Why?
Anxiety Disorders
1
2016
60
0.500
Why?
Retrospective Studies
17
2022
2546
0.500
Why?
Carboxylesterase
1
2015
1
0.490
Why?
Patient Preference
4
2025
32
0.490
Why?
Fluorouracil
6
2022
58
0.480
Why?
Pilot Projects
4
2024
433
0.470
Why?
Immunotherapy
5
2022
160
0.470
Why?
Research Design
1
2016
184
0.470
Why?
Life Style
1
2015
89
0.460
Why?
Health Knowledge, Attitudes, Practice
1
2017
297
0.450
Why?
Leucovorin
5
2022
19
0.440
Why?
Rectal Neoplasms
2
2025
9
0.430
Why?
Follow-Up Studies
8
2019
1013
0.420
Why?
Hospitals, Special
1
2013
3
0.420
Why?
ADP-ribosyl Cyclase 1
1
2013
10
0.420
Why?
Chemoradiotherapy
3
2024
44
0.410
Why?
Chemokines
1
2013
74
0.410
Why?
Quality Assurance, Health Care
1
2013
62
0.400
Why?
Survival Rate
9
2020
430
0.400
Why?
Analgesics
1
2012
38
0.400
Why?
Veterans
1
2013
69
0.390
Why?
Aging
2
2019
968
0.380
Why?
Neoplasm Metastasis
6
2020
162
0.380
Why?
Lymphoma, Non-Hodgkin
2
2021
26
0.370
Why?
Neoplasm Staging
5
2019
478
0.360
Why?
Pain
2
2015
258
0.360
Why?
Cytokines
1
2013
447
0.350
Why?
Circulating Tumor DNA
2
2021
2
0.350
Why?
Antiemetics
2
2020
4
0.350
Why?
Insurance, Health
4
2021
51
0.350
Why?
Psychometrics
4
2019
121
0.350
Why?
Socioeconomic Factors
4
2019
250
0.350
Why?
Massachusetts
3
2019
16
0.340
Why?
Precision Medicine
2
2021
76
0.340
Why?
Ambulatory Care
2
2021
60
0.340
Why?
Stress, Psychological
4
2021
221
0.340
Why?
Goals
2
2020
34
0.330
Why?
Combined Modality Therapy
3
2025
300
0.320
Why?
Gastroenterologists
2
2019
6
0.320
Why?
End Stage Liver Disease
2
2019
9
0.310
Why?
Intensive Care Units
2
2019
50
0.310
Why?
Antineoplastic Agents, Immunological
2
2020
42
0.310
Why?
Patient Care Planning
2
2020
24
0.310
Why?
Kaplan-Meier Estimate
3
2018
194
0.300
Why?
Patient Discharge
2
2020
104
0.290
Why?
Health Care Surveys
2
2018
67
0.290
Why?
Neoplasm Recurrence, Local
3
2018
330
0.280
Why?
Patient Outcome Assessment
2
2019
14
0.270
Why?
Adolescent
5
2023
3121
0.270
Why?
Cachexia
2
2020
53
0.270
Why?
Oncologists
3
2021
15
0.260
Why?
Family
2
2017
98
0.260
Why?
Biomarkers, Tumor
3
2023
404
0.260
Why?
Liver Neoplasms
2
2020
165
0.250
Why?
Longitudinal Studies
4
2023
414
0.250
Why?
Cancer Pain
1
2025
12
0.230
Why?
Feasibility Studies
2
2025
193
0.230
Why?
Cost Savings
1
2024
19
0.230
Why?
Mass Screening
2
2024
152
0.220
Why?
Nausea
2
2020
17
0.220
Why?
Vomiting
2
2020
14
0.220
Why?
Biomedical Research
1
2025
97
0.220
Why?
Autoimmune Diseases
1
2025
164
0.210
Why?
Natural Language Processing
1
2023
17
0.210
Why?
Qualitative Research
4
2025
192
0.200
Why?
Lymphoma, Large B-Cell, Diffuse
1
2023
28
0.200
Why?
Coronary Vasospasm
1
2022
4
0.200
Why?
Prescriptions
1
2022
3
0.190
Why?
Mutation
3
2021
845
0.190
Why?
Cancer Care Facilities
1
2021
9
0.190
Why?
Logistic Models
3
2020
407
0.190
Why?
Lymphoma, Follicular
1
2021
13
0.190
Why?
Neoplasm, Residual
1
2021
31
0.180
Why?
Patient Satisfaction
1
2022
96
0.180
Why?
Mental Health Services
1
2021
20
0.180
Why?
Videoconferencing
1
2021
10
0.180
Why?
Telephone
1
2021
26
0.180
Why?
Gastroenterology
1
2021
15
0.180
Why?
Inflammatory Bowel Diseases
1
2021
44
0.180
Why?
Research
1
2021
92
0.180
Why?
Genetic Predisposition to Disease
1
2024
666
0.180
Why?
Siblings
2
2018
23
0.180
Why?
Fellowships and Scholarships
1
2021
39
0.180
Why?
Tomography, X-Ray Computed
2
2021
474
0.170
Why?
Poverty
2
2024
89
0.170
Why?
Neoplasms, Second Primary
1
2020
21
0.170
Why?
Weight Loss
1
2021
81
0.170
Why?
Fatigue
3
2020
64
0.170
Why?
Practice Patterns, Physicians'
1
2022
163
0.170
Why?
Anus Neoplasms
1
2020
5
0.170
Why?
Child
4
2021
2242
0.170
Why?
Indians, North American
1
2024
520
0.170
Why?
Veterans Health
1
2019
6
0.170
Why?
Cell-Free Nucleic Acids
1
2019
4
0.160
Why?
Liquid Biopsy
1
2019
9
0.160
Why?
DNA, Neoplasm
1
2019
34
0.160
Why?
Losartan
1
2019
4
0.160
Why?
Nursing Homes
1
2019
48
0.160
Why?
Guideline Adherence
1
2020
95
0.160
Why?
Public Health Surveillance
1
2019
6
0.160
Why?
Sexual Behavior
1
2020
91
0.160
Why?
Pandemics
1
2021
186
0.160
Why?
High-Throughput Nucleotide Sequencing
1
2020
109
0.160
Why?
Carcinoma, Hepatocellular
1
2020
131
0.160
Why?
Advance Care Planning
1
2019
14
0.150
Why?
Carcinoma, Large Cell
1
2018
6
0.150
Why?
Quality of Health Care
2
2021
80
0.150
Why?
Atrial Fibrillation
1
2023
402
0.150
Why?
Attitude
1
2019
44
0.150
Why?
Decision Support Techniques
1
2018
50
0.150
Why?
Chemoradiotherapy, Adjuvant
1
2018
12
0.150
Why?
Prescription Fees
1
2018
3
0.150
Why?
Psychological Tests
1
2018
21
0.150
Why?
Adipose Tissue
1
2020
183
0.150
Why?
Liver Transplantation
1
2019
56
0.150
Why?
Antibodies, Monoclonal, Humanized
2
2020
144
0.150
Why?
Costs and Cost Analysis
1
2018
40
0.150
Why?
Program Evaluation
1
2019
167
0.150
Why?
Delivery of Health Care, Integrated
1
2018
14
0.150
Why?
Tumor Burden
1
2018
110
0.150
Why?
Health Services Needs and Demand
1
2018
37
0.150
Why?
Managed Care Programs
1
2018
16
0.150
Why?
Anorexia
2
2015
4
0.150
Why?
Time-to-Treatment
1
2018
27
0.150
Why?
Terminally Ill
1
2017
2
0.140
Why?
Employment
1
2018
49
0.140
Why?
Blood Vessels
1
2018
59
0.140
Why?
Resuscitation Orders
1
2017
9
0.140
Why?
Attitude to Death
1
2017
13
0.140
Why?
Professional-Patient Relations
1
2017
28
0.140
Why?
Regression Analysis
1
2018
210
0.140
Why?
Pancreaticoduodenectomy
1
2017
42
0.140
Why?
Health Surveys
1
2017
82
0.140
Why?
Postoperative Complications
1
2022
611
0.140
Why?
Endocrine Gland Neoplasms
1
2017
2
0.140
Why?
Aromatase Inhibitors
1
2017
2
0.140
Why?
Financial Support
1
2016
9
0.130
Why?
Hospital Mortality
1
2017
147
0.130
Why?
Molecular Targeted Therapy
1
2018
135
0.130
Why?
Psychiatric Status Rating Scales
1
2017
98
0.130
Why?
Interpersonal Relations
1
2017
65
0.130
Why?
Glioma
1
2018
117
0.130
Why?
Guidelines as Topic
1
2016
46
0.130
Why?
Health Status
1
2017
148
0.130
Why?
Physicians
1
2016
83
0.120
Why?
Forecasting
1
2016
76
0.120
Why?
Melanoma
1
2017
141
0.120
Why?
Brazil
2
2025
24
0.120
Why?
African Americans
1
2018
352
0.120
Why?
Delphi Technique
1
2015
21
0.120
Why?
Evidence-Based Medicine
1
2016
145
0.120
Why?
Social Support
1
2016
126
0.120
Why?
Organoplatinum Compounds
1
2015
24
0.120
Why?
Emotions
1
2016
133
0.120
Why?
Sex Characteristics
1
2015
172
0.120
Why?
Bevacizumab
1
2015
103
0.110
Why?
Colonic Neoplasms
1
2016
121
0.110
Why?
Cohort Studies
3
2023
887
0.110
Why?
Body Weight
1
2014
250
0.110
Why?
Prostatic Neoplasms
1
2017
277
0.110
Why?
Frail Elderly
1
2013
15
0.110
Why?
Quality Indicators, Health Care
1
2013
49
0.100
Why?
Lymphatic Metastasis
3
2018
125
0.100
Why?
Consultants
1
2012
4
0.100
Why?
Data Collection
1
2013
105
0.100
Why?
Quality Improvement
1
2013
115
0.100
Why?
Time Factors
3
2020
1591
0.090
Why?
Gene Expression
1
2013
417
0.090
Why?
Cognition Disorders
1
2013
184
0.090
Why?
Glucose Intolerance
1
2011
23
0.090
Why?
Magnesium
1
2011
42
0.090
Why?
Comorbidity
2
2023
258
0.090
Why?
Proto-Oncogene Proteins B-raf
2
2021
31
0.090
Why?
Polycystic Ovary Syndrome
1
2011
65
0.080
Why?
Pain Measurement
2
2025
166
0.080
Why?
Postural Balance
1
2009
41
0.080
Why?
Hospices
2
2020
6
0.080
Why?
Insulin Resistance
1
2011
175
0.080
Why?
Survivorship
2
2021
11
0.080
Why?
Exercise Test
1
2009
248
0.080
Why?
Walking
1
2009
135
0.070
Why?
Hypertension
1
2011
308
0.070
Why?
Programmed Cell Death 1 Receptor
2
2018
39
0.070
Why?
B7-H1 Antigen
2
2018
38
0.070
Why?
Karnofsky Performance Status
2
2020
15
0.070
Why?
Incidence
2
2021
562
0.070
Why?
Neoplasm Invasiveness
2
2018
190
0.070
Why?
Survival Analysis
2
2020
288
0.070
Why?
Awareness
1
2025
16
0.060
Why?
Body Mass Index
2
2021
399
0.060
Why?
Charities
1
2025
1
0.060
Why?
Obesity
1
2011
669
0.060
Why?
Patient Care Team
1
2024
67
0.060
Why?
Child, Preschool
2
2018
1146
0.060
Why?
Carcinoembryonic Antigen
1
2023
3
0.050
Why?
Bendamustine Hydrochloride
1
2023
2
0.050
Why?
Bone Marrow Transplantation
1
2023
49
0.050
Why?
Rituximab
1
2023
63
0.050
Why?
Electronic Health Records
1
2023
61
0.050
Why?
Minority Groups
1
2023
70
0.050
Why?
Calcium Channel Blockers
1
2022
40
0.050
Why?
Nitrates
1
2022
51
0.050
Why?
Microsatellite Repeats
1
2021
56
0.050
Why?
Drug Costs
1
2021
17
0.050
Why?
Drugs, Generic
1
2021
6
0.050
Why?
Radiotherapy
1
2021
41
0.050
Why?
Pharmacies
1
2021
19
0.050
Why?
Hematologic Tests
1
2021
7
0.050
Why?
Biological Specimen Banks
1
2021
10
0.050
Why?
Immunologic Factors
1
2021
49
0.050
Why?
Oncology Service, Hospital
1
2020
1
0.040
Why?
New England
1
2020
8
0.040
Why?
alpha-Fetoproteins
1
2020
18
0.040
Why?
Hospital Costs
1
2020
29
0.040
Why?
Hospitals
1
2021
77
0.040
Why?
Transportation of Patients
1
2020
29
0.040
Why?
Sexual Dysfunction, Physiological
1
2020
6
0.040
Why?
Pneumonia, Aspiration
1
2019
4
0.040
Why?
Dehydration
1
2019
6
0.040
Why?
Renal Insufficiency
1
2019
20
0.040
Why?
Health Planning Guidelines
1
2019
6
0.040
Why?
Perception
1
2020
88
0.040
Why?
Whole Exome Sequencing
1
2019
9
0.040
Why?
Autopsy
1
2019
25
0.040
Why?
Radiation Injuries
1
2020
52
0.040
Why?
Genetic Heterogeneity
1
2019
31
0.040
Why?
Urinary Tract Infections
1
2019
39
0.040
Why?
Intersectoral Collaboration
1
2019
7
0.040
Why?
Waiting Lists
1
2019
10
0.040
Why?
Databases, Factual
1
2020
253
0.040
Why?
Odds Ratio
1
2019
236
0.040
Why?
Cultural Competency
1
2019
18
0.040
Why?
Pneumonia
1
2019
89
0.040
Why?
Sepsis
1
2019
84
0.040
Why?
Referral and Consultation
1
2019
97
0.040
Why?
Proportional Hazards Models
1
2018
226
0.040
Why?
Drug Resistance, Neoplasm
1
2019
167
0.040
Why?
Disease Progression
1
2020
473
0.040
Why?
Antacids
1
2017
6
0.040
Why?
Enzyme Replacement Therapy
1
2017
4
0.040
Why?
Attitude of Health Personnel
1
2019
143
0.040
Why?
Models, Statistical
1
2018
128
0.040
Why?
Pancreatic Diseases
1
2017
13
0.040
Why?
Cause of Death
1
2017
73
0.030
Why?
Cardiopulmonary Resuscitation
1
2017
28
0.030
Why?
Needs Assessment
1
2017
55
0.030
Why?
Tamoxifen
1
2017
33
0.030
Why?
Disease-Free Survival
1
2017
237
0.030
Why?
Family Health
1
2016
71
0.030
Why?
Linear Models
1
2016
202
0.030
Why?
Mental Health
1
2016
99
0.030
Why?
Antibodies, Monoclonal
1
2017
329
0.030
Why?
Dyspnea
1
2015
25
0.030
Why?
Risk Assessment
1
2017
612
0.030
Why?
Constipation
1
2015
22
0.030
Why?
Infant, Newborn
1
2018
885
0.030
Why?
Internationality
1
2014
31
0.030
Why?
Syndrome
1
2014
78
0.030
Why?
Infant
1
2018
1004
0.030
Why?
Consensus
1
2014
75
0.030
Why?
Risk Factors
1
2020
2081
0.030
Why?
Terminology as Topic
1
2014
56
0.030
Why?
Prevalence
1
2015
497
0.030
Why?
Waist Circumference
1
2011
20
0.020
Why?
Body Weights and Measures
1
2009
18
0.020
Why?
Hand Strength
1
2009
38
0.020
Why?
Accidental Falls
1
2009
32
0.020
Why?
Blood Pressure
1
2011
354
0.020
Why?
Lipids
1
2011
208
0.020
Why?
Gait
1
2009
61
0.020
Why?
Blood Glucose
1
2011
309
0.020
Why?
Analysis of Variance
1
2009
391
0.020
Why?
Chronic Disease
1
2009
271
0.020
Why?
Heart Rate
1
2009
379
0.020
Why?
Biomarkers
1
2011
765
0.020
Why?
Nipp's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (381)
Explore
_
Co-Authors (34)
Explore
_
Similar People (58)
Explore
_
Same Department Expand Description
Explore
_